首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 生物科技 > 以基因為基之藥物開發 > 識別目標與確認效果用的High-Content Screening
產業/市場分類
生物科技 (1466)
分子標靶治療學 (51)
生技設備 (319)
生物材料 (55)
生物標記 (156)
以基因為基之藥物開發 (201)
再生醫學 (120)
抗體和免疫 (187)
個人化醫學 (54)
基因治療學和RNAi (100)
市場調查報告書

識別目標與確認效果用的High-Content Screening

High-Content Screening for Target Identification and Validation

出版商 Technical Insights, Inc.
出版日期 2006年06月 商品編碼 45011
內容資訊 英文 92 Pages
價格
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


識別目標與確認效果用的High-Content Screening 是由出版商Technical Insights, Inc.在2006年06月所出版的。 這份英文市場調查報告書包含92 Pages 價格從美金6000起跳。

簡介

隨著低侵入性手術普遍,内視鏡檢查的需求也逐漸增加。與傳統的切開手術比較,利用內視鏡更能節省成本是刺激需求的主要原因之一。

專門於多樣先進產業相關策略性調查的美國市調公司 Technical Insights, Inc. (總公司:德州),針對HCS(精確識別目標及分析變化)技術進行調查分析,經系統整理調查結果後出版報告書 "High-Content Screening for Target Identification and Validation"

本報告書內容包括:HCS技術概要、技術與應用趨勢,以及美國、歐洲、日本各地技術創新趨勢等。內容綱要摘記如下:

第1章 實施概要

  • 調查範圍及方法
    • 範圍
    • 方法
  • 主要觀點
    • 介紹
    • 值得一提的新興技術與應用
    • 競爭技術評估

第2章 技術及應用趨勢

  • 技術及應用分析
    • 技術趨勢
    • High-Content Screening及競爭技術
  • 技術採用因素
    • 刺激因素
    • 課題
    • 抑制因素
  • 未來趨勢、融資、合作
    • 技術及應用趨勢
    • 融資分析
    • 合作

第3章 技術創新及機會評估:美國

  • 北美的技術發展及創新
    • iCyte影像血球計算器
    • Thermo Electron Coporation的HCS cellWorx
    • Molecular Devices Corporation的新型自動顯微鏡
    • Cellumen開發的多重HCS平台
    • BD Sciences開發的生物路徑成像系統
    • Applied Precision開發的cellWorx HCS分析系統
    • Metrigenics開發的微陣列平台
    • BioImage的二次銷售技術
  • 大學的技術發展及創新
    • Purdue University開發的多色BIFC測試
    • 針對内皮細胞釋放出的氧化氮的電化學HCS分析
    • 神經胺酸脢抑制劑的高效率分析
    • 促使細胞核分裂停止的小分子

第4章 歐洲、亞太地區的技術創新及機會

  • 企業的技術發展與創新
    • Evotec Technologies的Opera System:歐洲
    • Cellenger:Definiens開發的HCS設備:德國
    • IMSTAR開發的導航技術
    • Bionas分析系統
  • 大學的技術發展與創新
    • 基因解碼蛋白質的HCS:東京
    • HCS顯微鏡發現新的蛋白質:德國
    • 利用人體激酶siRNA庫的HCS:德國

第5章 專利、名詞解釋、主要業界企業

  • 主要專利
  • 聯絡對象及名詞解釋

第6章 Frost & Sullivan 獎

第7章 決策支援資料庫

  • 資料庫表
    • 醫療預算總額(1999年至2006年)
    • 藥品研發費用(1999年至2006年)
    • 政府的醫療預算(1999年至2006年)
    • 民間醫療支出(1999年至2006年)

目錄

Abstract

This Frost & Sullivan research service titled High Content Screening for Target Identification and Validation provides an overview of developments in the pharmaceuticals and clinical diagnostics industry, along with key drivers, influencing market factors, challenges, and analysis of trends recently witnessed. This research service thoroughly examines the drug discovery and therapeutics applications.

This research service is available through our Technical Insights Growth Partnership Services program. With this program you receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils. For more information on this custom subscription service, click here.

Frost & Sullivan Growth Partnership Service

Based on extensive and in-depth research, real-world consulting work, and new theories tested in hundreds of companies across many industries, Frost & Sullivan has evolved its Growth Partnership Services (GPS) program that provides established and emerging firms with powerful growth visions. Moving beyond token mission statements, GPS provides an actionable vision to growth consulting partners by illustrating how key intelligence and strategic research based on defined goals can guide day-to-day behavior and overall company direction. The foundation of Frost & Sullivan's GPS includes:

  • Assisting companies to reach their full potential in the core business
  • Providing growth strategies to help companies expand into related businesses
  • Preemptively redefining the core business during market turbulence
  • Applying the Frost & Sullivan framework to identify and address common mistakes resulting from misaligned corporate strategies
  • Recommending growth management strategies through continuous partnership

To maximize the potential for growth within a firm's internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programs that deliver improved market success. Frost & Sullivan's strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clients' growth.

Table of Contents

1 | EXECUTIVE SUMMARY

  • Scope and Methodology
    • 1. Scope
    • 2. Methodology
  • Key Findings
    • 1. Introduction
    • 2. Noteworthy Emerging Technologies and Applications
    • 3. Assessment of Competing Technologies

2 | TECHNOLOGY AND APPLICATIONS VIEWPOINT

  • Technology and Applications Analysis
    • 1. Technology Primer
    • 2. High Content Screening Vs. Competing Technologies
  • Technological Developments and Innovations in Companies
    • 1. cellWorx High Content Screening Analysis System developed by Applied Precision--USA
    • 2. Microarray Platform developed by Metrigenics--USA
    • 3. Acumen Explorer 488 developed by TTP LabTech--USA
    • 4. Redistribution Technology by BioImage
  • Technology Adoption Factor
    • 1. Analysis of Technology Drivers
    • 2. Analysis of Technology Challenges
    • 3. Analysis of Technology Restraints
  • Future Trends; Capital Funding; Partnerships and Alliances
    • 1. Technology and Application Trends
    • 2. Capital Funding Analysis
    • 3. Partnerships and Alliances

3 | ASSESSMENT OF INNOVATIONS AND OPPORTUNITIES- USA

  • Technological Developments and Innovations in Universities
    • 1. High-Throughput Screening of Neuraminidase Inhibitors--USA
    • 2. A Small Molecule that Induces Mitotic Arrest--USA

4 | ASSESSMENT OF INNOVATIONS AND OPPORTUNITIES- EUROPE AND ASIA PACIFIC

  • Technological Developments and Innovations in Companies
    • 1. Multicolor Color BiFC Assays Developed by Purdue University--USA
    • 2. Electrochemical High-Content Screening of Nitric Oxide Release from Endothelial Cells--USA
    • 3. Cellenger- A High Content Screening Instrument developed by Definiens--Germany
    • 4. High-Content Screening Microscopy Identifies Novel Proteins--Germany
    • 5. Pathfinder Technology developed by IMSTAR
    • 6. Bionas Analyzing System
  • Technological Developments and Innovations in Universities
    • 1. A High-throughput screening of Genes Encoding Proteins--Tokyo
    • 2. High-Content Screening Using a Human Kinase siRNA Library--Germany

5 | KEY PATENTS; CONTACTS; GLOSSARY

  • Key Patents
    • 1. US Patents; 2006
    • 2. US Patents; 2005
  • Contacts and Glossary
    • 1. Database of Key industry Participants
    • 2. University Participants
    • 3. Glossary

6 | FROST & SULLIVAN 2006 SCIENCE AND TECHNOLOGY AWARDS

  • Product Innovation Award
    • 1. Award Description
    • 2. Award Recipient
  • Technology Innovation Award
    • 1. Award Description
    • 2. Award Recipient
  • Excellence in Technology
    • 1. Award Description
    • 2. Award Recipient

7 | DECISION SUPPORT DATABASE

  • Database Tables
    • 1. Total Healthcare Expenditure (1999-2006)
    • 2. Pharma R&D Expenditure (1999-2006)
    • 3. Govt Biotech R&D Investment (1999-2006)
    • 4. Private Biotech R&D Investment (1999-2006)
Back to Top